Alan Menter

Alan Menter

UNVERIFIED PROFILE

Are you Alan Menter?   Register this Author

Register author
Alan Menter

Alan Menter

Publications by authors named "Alan Menter"

Are you Alan Menter?   Register this Author

100Publications

1264Reads

Prevalence of genital psoriasis in patients with psoriasis.

J Dermatolog Treat 2018 Dec 28;29(8):754-760. Epub 2018 Mar 28.

f Baylor University Medical Center , Dallas , TX , USA.

View Article
December 2018

Anti-IL17 therapies for psoriasis.

Expert Opin Biol Ther 2018 Nov 30. Epub 2018 Nov 30.

a Division of Dermatology , Baylor Scott and White - Dallas , Dallas , TX , USA.

View Article
November 2018

Risankizumab: an anti-IL-23 antibody for the treatment of psoriasis.

Drug Des Devel Ther 2018 12;12:3879-3883. Epub 2018 Nov 12.

Department of Dermatology, Baylor University Medical Center, Dallas, TX, USA,

View Article
November 2018

IL-17 inhibitors for psoriasis.

Semin Cutan Med Surg 2018 Sep;37(3):148-157

Division of Dermatology, Baylor University Medical Center, Dallas, Texas, USA.

View Article
September 2018

Histiocytoid Sweet syndrome successfully treated with etanercept.

Proc (Bayl Univ Med Cent) 2018 Jul 9;31(3):347-349. Epub 2018 May 9.

Department of Dermatology, Baylor University Medical Center, Dallas, Texas.

View Article
July 2018

Pharmacotherapeutic approaches for treating psoriasis in difficult-to-treat areas.

Expert Opin Pharmacother 2018 Apr 22;19(6):561-575. Epub 2018 Mar 22.

a Division of Dermatology , Baylor Scott and White , Dallas , TX , USA.

View Article
April 2018

Symptomatic hypercalcemia and scarring alopecia as presenting features of sarcoidosis.

Proc (Bayl Univ Med Cent) 2018 Apr 15;31(2):224-226. Epub 2018 Mar 15.

Division of Dermatology, Baylor University Medical Center, Dallas, Texas.

View Article
April 2018

Introduction.

Authors:
Alan M Menter

Semin Cutan Med Surg 2018 Feb;37(2S):S38

Chairman, Division of Dermatology Baylor University Medical Center Dallas, Texas.

View Article
February 2018

The Evolving Landscape of Psoriasis Treatment.

Semin Cutan Med Surg 2018 Feb;37(2S):S39-S43

Director of Dermatology Research Department of Dermatology Kaiser Permanente Los Angeles Medical Center Los Angeles, California.

View Article
February 2018

Treating to Target-A Realistic Goal in Psoriasis?

Semin Cutan Med Surg 2018 Feb;37(2S):S44-S47

Director of Dermatology Research Department of Dermatology Kaiser Permanente Los Angeles Medical Center Los Angeles, California.

View Article
February 2018

Common and Not-So-Common Comorbidities of Psoriasis.

Semin Cutan Med Surg 2018 Feb;37(2S):S48-S51

Director of Dermatology Research Department of Dermatology Kaiser Permanente Los Angeles Medical Center Los Angeles, California.

View Article
February 2018

Practical Strategies for Optimizing Management of Psoriasis.

Semin Cutan Med Surg 2018 Feb;37(2S):S52-S55

Chairman, Division of Dermatology Baylor University Medical Center Dallas, Texas.

View Article
February 2018

Anti-IL-23 and Anti-IL-17 Biologic Agents for the Treatment of Immune-Mediated Inflammatory Conditions.

Clin Pharmacol Ther 2018 Jan 19;103(1):88-101. Epub 2017 Oct 19.

Baylor Scott and White, Division of Dermatology, Dallas, Texas, USA.

View Article
January 2018

The impact of biologic agents on health-related quality of life outcomes in patients with psoriasis.

Expert Rev Clin Immunol 2018 01 22;14(1):1-19. Epub 2017 Nov 22.

a Division of Dermatology , Baylor University Medical Center , Dallas , TX , USA.

View Article
January 2018

Secukinumab: a review of the anti-IL-17A biologic for the treatment of psoriasis.

Ther Adv Chronic Dis 2018 Jan 16;9(1):5-21. Epub 2017 Nov 16.

Baylor Scott and White- Division of Dermatology, 3900 Junius Street, Suite 125, Dallas, TX 75246, USA.

View Article
January 2018

Spectrum of orocutaneous disease associations: Immune-mediated conditions.

J Am Acad Dermatol 2017 Nov;77(5):795-806

Division of Dermatology, Baylor University Medical Center, Dallas, Texas. Electronic address:

View Article
November 2017

Spectrum of orocutaneous disease associations: Genodermatoses and inflammatory conditions.

J Am Acad Dermatol 2017 Nov;77(5):809-830

Division of Dermatology, Baylor University Medical Center, Dallas, Texas. Electronic address:

View Article
November 2017

A review article on brodalumab in the treatment of moderate-to-severe plaque psoriasis.

Immunotherapy 2017 09 7;9(12):963-978. Epub 2017 Sep 7.

Division of Dermatology, Baylor Scott & White, Dallas, TX 75246, USA.

View Article
September 2017

Prevalence of psoriasis in Brazil - a geographical survey.

Int J Dermatol 2017 08 27;56(8):e167-e168. Epub 2017 Mar 27.

Department of Dermatology, FMB-Unesp, Botucatu, SP, Brazil.

View Article
August 2017

Calcipotriene betamethasone dipropionate aerosol foam in the treatment of plaque psoriasis: a review of the literature.

Ther Deliv 2017 08 29;8(9):737-746. Epub 2017 Jun 29.

Division of Dermatology, Baylor University Medical Center, 3900 Junius Street, Suite 125, Dallas, TX 75246, USA.

View Article
August 2017

Adalimumab in paediatric psoriasis.

Lancet 2017 07 4;390(10089):5-6. Epub 2017 May 4.

Baylor University Medical Center, Dallas, TX 75246, USA. Electronic address:

View Article
July 2017

Coronary Plaque Characterization in Psoriasis.

Circulation 2017 Jul;136(3):277-280

From Division of Dermatology (D.K., A.M.) and Department of Cardiology (J.M.S), Baylor Scott & White and Texas A&M College of Medicine, Dallas.

View Article
July 2017

Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam in Patients with Moderate-to-Severe Psoriasis: Sub-Group Analysis of the PSO-ABLE Study.

Am J Clin Dermatol 2017 Jun;18(3):405-411

Department of Dermatology, Icahn School of Medicine at Mount Sinai, 5 E 98th St, New York, NY, 10029, USA.

View Article
June 2017

Evaluation and management of an unusual congenital nevus.

Proc (Bayl Univ Med Cent) 2017 Apr;30(2):211-212

Texas A&M College of Medicine (Kerwin, Menter), Baylor University Medical Center at Dallas (Menter), and Texas Dermatology Associates, P.A., Dallas, Texas (Menter).

View Article
April 2017

Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis.

N Engl J Med 2017 04;376(16):1551-1560

From K. Papp Clinical Research and Probity Medical Research, Waterloo, ON (K.A.P.), School of Medicine, Queen's University, Kingston, ON (M.G.), and Centre for Dermatology and Probity Medical Research, Peterborough, ON (M.G.) - all in Canada; Oregon Medical Research Center, Portland (A.B.); Altman Dermatology Associates, Arlington Heights, IL (M.B.); Rockefeller University, New York (J.K.); Hôpital de l'Archet, University of Nice-Sophia Antipolis, Nice, France (J.-P.L.); Baylor Research Institute, Dallas (A.M.); Charité Universitätsmedizin Berlin, Berlin (S.P.), Boehringer Ingelheim Pharma, Biberach (B.R.B.), and Boehringer Ingelheim Pharma, Ingelheim, (S.J.P.) - all in Germany; University of Texas Health Science Center, Houston (S.T.); University of California, Los Angeles, School of Medicine, Los Angeles (H.S.); and Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT (S.V., C.P., N.B., M.F., P.S.).

View Article
April 2017

Ethical dilemma in missed melanoma: What to tell the patient and other providers.

J Am Acad Dermatol 2017 Feb;76(2):365-367

Division of Dermatology, Baylor University Medical Center, Dallas, Texas.

View Article
February 2017

Efficacy of Secukinumab on Moderate-to-severe Plaque Psoriasis Affecting Different Body Regions: a Pooled Analysis of Four Phase 3 Studies.

Dermatol Ther (Heidelb) 2016 Dec 30;6(4):639-647. Epub 2016 Aug 30.

Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.

View Article
December 2016

A review of emerging IL-17 inhibitors in the treatment of psoriasis focusing on preclinical through phase II studies.

Expert Opin Investig Drugs 2016 Nov 30;25(11):1337-1344. Epub 2016 Sep 30.

a Division of Dermatology , Baylor University Medical Center , Dallas , TX , USA.

View Article
November 2016

Pustular psoriasis eruption with dabrafenib, a BRAF inhibitor.

J Dermatolog Treat 2016 Oct 14;27(5):418-21. Epub 2016 Apr 14.

a Department of Dermatology , Baylor University Medical Center , Dallas , TX , USA.

View Article
October 2016

Erratum to: Letter from the Editors.

Dermatol Ther (Heidelb) 2016 Jun;6(2):303

Dermatological Sciences, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.

View Article
June 2016

Erratum to: A Review of Biologic Therapies Targeting IL-23 and IL-17 for Use in Moderate-to-Severe Plaque Psoriasis.

Dermatol Ther (Heidelb) 2016 Jun;6(2):305

Division of Dermatology, Baylor University Medical Center, Dallas, TX, USA.

View Article
June 2016

Psoriasis and psoriatic arthritis overview.

Authors:
Alan Menter

Am J Manag Care 2016 Jun;22(8 Suppl):s216-24

View Article
June 2016

Psoriasis and psoriatic arthritis treatment.

Authors:
Alan Menter

Am J Manag Care 2016 Jun;22(8 Suppl):s225-37

View Article
June 2016

An overview of developing TNF-α targeted therapy for the treatment of psoriasis.

Expert Opin Investig Drugs 2015 8;24(10):1343-54. Epub 2015 Aug 8.

a Baylor University Medical Center, Division of Dermatology , Dallas, TX, USA

View Article
May 2016

A Review of Biologic Therapies Targeting IL-23 and IL-17 for Use in Moderate-to-Severe Plaque Psoriasis.

Dermatol Ther (Heidelb) 2016 Mar 29;6(1):1-12. Epub 2015 Dec 29.

Division of Dermatology, Baylor University Medical Center, Dallas, TX, USA.

View Article
March 2016

Translating psoriasis guidelines into practice: Important gaps revealed.

J Am Acad Dermatol 2016 Mar 14;74(3):544-51. Epub 2016 Jan 14.

Baylor University Medical Center, Dallas, Texas.

View Article
March 2016

Use of brodalumab for the treatment of psoriasis and psoriatic arthritis.

Immunotherapy 2015 ;7(4):323-33

Baylor University Medical Center, 3900 Junius Street, Suite 125, Dallas, TX 75246, USA.

View Article
February 2016

The spectrum of nephrocutaneous diseases and associations: Genetic causes of nephrocutaneous disease.

J Am Acad Dermatol 2016 Feb;74(2):231-44; quiz 245-6

Department of Dermatology, Baylor University Medical Center, Dallas, Texas. Electronic address:

View Article
February 2016

The spectrum of nephrocutaneous diseases and associations: Inflammatory and medication-related nephrocutaneous associations.

J Am Acad Dermatol 2016 Feb;74(2):247-70; quiz 271-2

Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address:

View Article
February 2016

Recurrent lumbosacral herpes simplex virus infection.

Proc (Bayl Univ Med Cent) 2016 Jan;29(1):48-9

Loma Linda University School of Medicine, Loma Linda, California (Vassantachart), and the Division of Dermatology, Baylor University Medical Center at Dallas (Menter).

View Article
January 2016

Ustekinumab in adolescent patients age 12 to 17 years with moderate-to-severe plaque psoriasis: results of the randomized phase 3 CADMUS study.

J Am Acad Dermatol 2015 Oct 7;73(4):594-603. Epub 2015 Aug 7.

Janssen Research & Development, LLC., Spring House, Pennsylvania; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

View Article
October 2015

Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis.

N Engl J Med 2015 Oct;373(14):1318-28

From the Icahn School of Medicine at Mount Sinai, New York (M.L., L.K.); University of Connecticut School of Medicine, Farmington (B.S.); Probity Medical Research (B.S., L.S., D.T.) and XLR8 Medical Research (D.T.), Windsor, ON, K Papp Medical Research (K.P.), Waterloo, ON, and Dalhousie University, Halifax, NS (R.G.L.) - all in Canada; Baylor University Medical Center, Dallas (A.M.); Northwestern University, Feinberg School of Medicine, Chicago (K.G.); Niepubliczny Zakład Opieki Zdrowotnej multiMedica, Wrocław (J.W.), and Lubelskie Centrum Diagnostyczne, Świdnik (T.B.) - both in Poland; Hospital de la Santa Creu i Sant Pau, Barcelona (L.P.); Veracity Clinical Research, Woolloongabba, QLD, Australia (L.S.); Florida Academic Dermatology Center, Miami (F.K.); University of Colorado, Denver (A.W.A.); Medizinische Universität Wien, Vienna, Austria (G.S.); Massachusetts General Hospital and Harvard Medical School, Boston (A.B.K.); Sorbonne Paris Cité Université Paris Diderot, Assistance Publique-Hôpitaux de Paris Hôpital Saint Louis, Paris (H.B.), Paul Sabatier University, Toulouse (C.P.), and University Hospital of Nice, Nice (J.-P.L.) - all in France; Kaiser Permanente Los Angeles Medical Center, Los Angeles (J.J.W.), Bakersfield Dermatology and Skin Cancer Medical Group, Bakersfield (J.C.), University of California, San Francisco, San Francisco (J.K.), and Amgen, Thousand Oaks (G.A., J.L., W.S., C.E.M., Y.S., N.E., P.K., B.K., A.N.) - all in California.; University of Texas Health Science Center, Houston (S.T.); DermResearch, Louisville, KY (L.K.); University of Rome Tor Vergata, Rome (S.C.); University of Utah Medical Center, Salt Lake City (K.C.D.); and the Psoriasis Treatment Center of Central New Jersey, East Windsor (J.B.).

View Article
October 2015

Reporting of MABp1 for the Treatment of Psoriasis.

JAMA Dermatol 2015 Oct;151(10):1143-4

Division of Dermatology, Baylor University Medical Center, Dallas, Texas.

View Article
October 2015

Emerging oral drugs for psoriasis.

Expert Opin Emerg Drugs 2015 Jun 3;20(2):209-20. Epub 2015 Feb 3.

Texas A&M Health Science Center College of Medicine , 8447 Texas 47, Bryan, TX 77807 , USA.

View Article
June 2015

Genital psoriasis is associated with significant impairment in quality of life and sexual functioning.

J Am Acad Dermatol 2015 Jun 29;72(6):978-83. Epub 2015 Mar 29.

Department of Dermatology, Baylor University Medical Center, Dallas, Texas; Department of Medical Education, Texas A&M Health Science Center, Dallas, Texas.

View Article
June 2015

Phototherapy in dermatology: A call for action.

J Am Acad Dermatol 2015 Jun;72(6):1078-80

Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York.

View Article
June 2015

Polymorphic blistering eruption and stomatitis in a patient with non-Hodgkin lymphoma.

JAMA Dermatol 2015 Apr;151(4):439-40

Baylor University Medical Center, Dallas, Texas.

View Article
April 2015

Awareness and engagement in political advocacy among dermatology residents: a needs assessment.

J Am Acad Dermatol 2015 Apr;72(4):730-2

Division of Dermatology, Baylor University Medical Center, Dallas, Texas.

View Article
April 2015

Skin cancer evaluation in transplant patients: a physician opinion survey with recommendations.

Clin Transplant 2015 Feb 20;29(2):110-7. Epub 2014 Dec 20.

Dermatology, Baylor University Medical Center, Dallas, TX, USA.

View Article
February 2015

Central obesity and high blood pressure in pediatric patients with atopic dermatitis.

JAMA Dermatol 2015 Feb;151(2):144-52

Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.

View Article
February 2015

Reply to: "Review of drug-related causes of oculocutaneous disease".

J Am Acad Dermatol 2015 Feb;72(2):362-3

Baylor University Medical Center, Dallas, Texas. Electronic address:

View Article
February 2015

Psoriasis: the future.

Dermatol Clin 2015 Jan;33(1):161-6

Dermatology Centre, Salford Royal Hospital, The University of Manchester, Manchester Academic Health Science Centre, Manchester M6 8HD, UK. Electronic address:

View Article
January 2015

The International Psoriasis Council: advancing knowledge, enhancing care.

Dermatol Clin 2015 Jan;33(1):ix-xii

Dermatology Centre, Salford Royal Hospital, The University of Manchester, Manchester Academic Health Science Centre, Manchester M6 8HD, UK. Electronic address:

View Article
January 2015

The Laugier-Hunziker syndrome.

Proc (Bayl Univ Med Cent) 2015 Jan;28(1):41-2

Texas A&M Health Science Center College of Medicine and Baylor University Medical Center at Dallas.

View Article
January 2015

Ponesimod--a future oral therapy for psoriasis?

Lancet 2014 Dec 10;384(9959):2006-8. Epub 2014 Aug 10.

Department of Dermatology, Baylor University Medical Center and Texas A&M Health Science Center, Dallas, TX 75246, USA. Electronic address:

View Article
December 2014

Safety and efficacy of brodalumab for psoriasis after 120 weeks of treatment.

J Am Acad Dermatol 2014 Dec 11;71(6):1183-1190.e3. Epub 2014 Oct 11.

Amgen Inc, Thousand Oaks, California.

View Article
December 2014

Petechial eruption on fingers. Dermatitis herpetiformis.

JAMA Dermatol 2014 Dec;150(12):1353-4

Baylor University Medical Center, Dallas, Texas.

View Article
December 2014

The use of tumor necrosis factor inhibitors in pregnancy: what is the evidence?

J Am Acad Dermatol 2014 Oct;71(4):829-31

Baylor University Medical Center, Dallas, Texas. Electronic address:

View Article
October 2014

Angiolymphoid hyperplasia with eosinophilia.

Proc (Bayl Univ Med Cent) 2014 Oct;27(4):336-7

Division of Dermatology, Department of Internal Medicine, Baylor University Medical Center at Dallas.

View Article
October 2014

Complementary data for long-term infliximab use in psoriasis.

J Am Acad Dermatol 2014 Sep;71(3):591

Division of Dermatology, Baylor University Medical Center, Dallas, Texas. Electronic address:

View Article
September 2014

Polymorphic plaques involving the face and extremities.

JAMA Dermatol 2014 Jun;150(6):643-4

Baylor University Medical Center, Dallas, Texas.

View Article
June 2014

Long term efficacy and safety of etanercept in the treatment of psoriasis and psoriatic arthritis.

Biologics 2014 17;8:169-82. Epub 2014 Apr 17.

Department of Dermatology, Baylor University Medical Center, Dallas, TX, USA.

View Article
June 2014

Hidradenitis suppurativa: update on diagnosis and treatment. Introduction.

Semin Cutan Med Surg 2014 Jun;33(3 Suppl):S47

Assistant Professor of Dermatology and Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.

View Article
June 2014

Recognizing and managing comorbidities and complications in hidradenitis suppurativa.

Authors:
Alan Menter

Semin Cutan Med Surg 2014 Jun;33(3 Suppl):S54-6

Chief, Division of Dermatology, Baylor University Medical Center; Clinical Professor of Dermatology, University of Texas, Southwestern Medical School; Director, Fellowship Program, Baylor Psoriasis Center; Chair, Psoriasis Guidelines Committee, American Academy of Dermatology; Director, Dermatology Residency Program, Baylor University Medical Center, Dallas, TX.

View Article
June 2014

What you should know about hidradenitis suppurativa (HS): information for patients.

Semin Cutan Med Surg 2014 Jun;33(3 Suppl):S60-1

Assistant Professor of Dermatology and Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.

View Article
June 2014

The spectrum of oculocutaneous disease: Part I. Infectious, inflammatory, and genetic causes of oculocutaneous disease.

J Am Acad Dermatol 2014 May;70(5):795.e1-25

Baylor University Medical Center, Dallas, Texas. Electronic address:

View Article
May 2014

The spectrum of oculocutaneous disease: Part II. Neoplastic and drug-related causes of oculocutaneous disease.

J Am Acad Dermatol 2014 May;70(5):821.e1-19

Baylor University Medical Center, Dallas, Texas. Electronic address:

View Article
May 2014

Ustekinumab for the treatment of psoriatic arthritis.

Expert Rev Clin Immunol 2014 Feb;10(2):189-202

Division of Dermatology, Baylor University Medical Center, Dallas, TX, USA.

View Article
February 2014

Reply: Genital edema in Crohn's disease.

J Am Acad Dermatol 2014 Feb;70(2):385

Baylor University Medical Center, Dallas, Texas. Electronic address:

View Article
February 2014

Reply: To PMID 23317980.

Authors:
Alan Menter

J Am Acad Dermatol 2014 Jan;70(1):198

Baylor University Medical Center, Dallas, Texas. Electronic address:

View Article
January 2014

Emerging topical treatments for psoriasis.

Expert Opin Emerg Drugs 2013 Dec;18(4):523-32

Baylor University Medical Center, Department of Dermatology , 3900 Junius Street, Suite 125, Dallas, TX 75246 , USA +1972 354 7988 ; +1 972 715 1460 ;

View Article
December 2013

Dermatology: future therapeutic perspectives.

Dermatol Ther (Heidelb) 2013 Dec 3;3(2):115-6. Epub 2013 Dec 3.

The Dermatology Centre, Salford Royal NHS Foundation Trust, University of Manchester, Manchester Academic Health Science Centre, Manchester, M6 8HD, UK,

View Article
December 2013